What is Moichor?
Moichor operates at the intersection of veterinary medicine and cutting-edge technology, aiming to revolutionize animal diagnostics. The company's core mission is to empower veterinarians by providing highly accurate diagnostic tools. This is achieved through a multidisciplinary approach, integrating the expertise of pathologists, engineers, and in-house veterinarians with advanced technologies such as artificial intelligence and computer vision. The company's commitment to innovation is further bolstered by the experienced eyes of its dedicated medical professionals, ensuring the highest standards of diagnostic precision.
How much funding has Moichor raised?
Moichor has raised a total of $4M across 1 funding round:
Angel/Seed
$4M
Angel/Seed (2021): $4M with participation from Y Combinator
Key Investors in Moichor
Y Combinator
Y Combinator is a renowned startup accelerator and seed funding provider, established in 2005, known for its significant role in nurturing early-stage technology companies.
What's next for Moichor?
With a recent major strategic investment and substantial total funding, Moichor is well-positioned for accelerated growth and further technological development. The company's focus on enhancing veterinary diagnostics through AI and computer vision suggests a strategic expansion into new markets or the enhancement of its existing service offerings. This capital infusion will likely fuel research and development, enabling Moichor to refine its AI algorithms, expand its pathology services, and potentially broaden its reach to a larger segment of the veterinary community. The company's trajectory indicates a strong potential for market leadership in the specialized field of animal diagnostics.
See full Moichor company page
